Average rate of Hb rise in 2 weeks with EPOGEN® use1
A 26-week, placebo-controlled study of 118 patients examined exercise tolerance and patient-reported physical function2,3*Increase in Hb levels from approximately 7 to 11 g/dL was associated with improved exercise tolerance
LIMITATIONS OF USE
- EPOGEN® has not been shown to improve quality of life, fatigue, or patient well-being.
- EPOGEN® is not indicated for use as a substitute for RBC transfusions in patients who require immediate correction of anemia.
Scroll down for additional Important Safety Information
An increase in Hb levels from approximately 7 to 11 g/dL was associated with improved patient-reported physical function
†SIP and KDQ are validated instruments that evaluate patient-reported outcomes.
- Four domains from the SIP were used to assess patient-reported physical function: Physical, Home Management, Ambulation, and Body Care and Movement.